Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Receivables - Other (2019 - 2023)

Updated

Vistagen Therapeutics (VTGN) recorded Receivables - Other of $380,000 in fiscal Q1 2024 (quarter ended Jun 30, 2023).

Analysis

Vistagen Therapeutics (VTGN) Receivables - Other (2019 - 2023) Analysis & Trends

At the end of FY2021 (ended Mar 31, 2021), Vistagen Therapeutics reported Receivables - Other of $40,600.

  • Across earlier fiscal years, Receivables - Other came in at $300,000 in FY2019.
  • The fiscal Q1 2024 figure is the lowest quarterly Receivables - Other since fiscal Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn
9 Gsk 193.54 Bn 176.38 Bn -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 380,000.00
Jun 30, 2021 44,000.00
Mar 31, 2021 40,600.00
Mar 31, 2019 300,000.00
API Access

Vistagen Therapeutics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=VTGN&period=max&api_key=YOUR_API_KEY